NEW YORK (GenomeWeb News) – Millipore has acquired Oxford, UK-based BioAnaLab in a bid to expand its biopharmaceutical services offerings into the European market.

The Billerica, Mass.-based life science tools provider did not disclose the purchase price. It said that BioAnaLab's services include assay transfer and development, validation and sample analysis, pharmacokinetics and toxicokinetics, immunogenicity, biological potency, and vaccine services.

Millipore said that it would strengthen BioAnaLab's offerings with its own expertise in biomarker analytical services.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.